Brief: Healthverity Partners With Recursion To Enhance Clinical Trial Analytics With Real-World Data
16/04/2025 13:42
April 16 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O: HEALTHVERITY PARTNERS WITH RECURSION TO ENHANCE CLINICAL TRIAL ANALYTICS WITH REAL-WORLD DATA Source text: ID:nPn9J0qjPa Further company coverage: RXRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million